When the CD47-SIRPα-Aβ pathway is blocked by inhibiting CD47, B-cell suppression may be reversed, thereby activating adaptive immunity, promoting antigen recognition and presentation, antibody production, and ADCC effects, etc., so that innate immunity and adaptive immunity can cooperate more effectively to fight against infection by foreign pathogens. The gene discussed is SIRPA; the disease is infection.